Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell-Type-Specific Gene Editing
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
CRISPR-Cas RNA-guided endonucleases hold great promise for disrupting or correcting genomic sequences through site-specific DNA cleavage and repair. However, the lack of methods for cell- and tissue-selective delivery currently limits both research and clinical uses of these enzymes. We report the design and in vitro evaluation of S. pyogenes Cas9 proteins harboring asialoglycoprotein receptor ligands (ASGPrL). In particular, we demonstrate that the resulting ribonucleoproteins (Cas9-ASGPrL RNP) can be engineered to be preferentially internalized into cells expressing the corresponding receptor on their surface. Uptake of such fluorescently labeled proteins in liver-derived cell lines HEPG2 (ASGPr+) and SKHEP (control; diminished ASGPr) was studied by live cell imaging and demonstrates increased accumulation of Cas9-ASGPrL RNP in HEPG2 cells as a result of effective ASGPr-mediated endocytosis. When uptake occurred in the presence of a peptide with endosomolytic properties, we observed receptor-facilitated and cell-type specific gene editing that did not rely on electroporation or the use of transfection reagents. Overall, these in vitro results validate the receptor-mediated delivery of genome-editing enzymes as an approach for cell-selective gene editing and provide a framework for future potential applications to hepatoselective gene editing in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This delivery mode can reduce possible off-target mutations relative to delivering Cas9-encoding DNA or mRNA due to the short half-life of RNPs 76,85-87 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [87]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationHigh-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Kim, S., Kim, D., Cho, S. W., Kim, J., & Kim, J.-S. (2014) · Genome Research · doi:10.1101/gr.171322.113 · Cited by 1,856
Endosomal escape pathways for delivery of biologicals
Varkouhi, A. K., Scholte, M., Storm, G., & Haisma, H. J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.004 · Cited by 1,561
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490
Zuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
Lin, S., Staahl, B. T., Alla, R. K., & Doudna, J. A. (2014) · eLife · doi:10.7554/elife.04766 · Cited by 1,189
Self-citationGene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Nair, J. K., Willoughby, J. L. S., Chan, A., Charisse, K., Alam, M. R., Wang, Q., Hoekstra, M., Kandasamy, P., Kel’in, A. V., Milstein, S., et al. (2014) · Journal of the American Chemical Society · doi:10.1021/ja505986a · Cited by 1,141
Overcoming cellular barriers for RNA therapeutics
Dowdy, S. F. (2017) · Nature Biotechnology · doi:10.1038/nbt.3802 · Cited by 1,139
Cited by
Items 101–170 of 170
Receptor-Targeted Dual pH-Triggered Intracellular Protein Transfer
Lyu, M., Yazdi, M., Lin, Y., Höhn, M., Lächelt, U., & Wagner, E. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00476 · Cited by 17
Responsive MXene nanovehicles deliver CRISPR/Cas12a for boolean logic-controlled gene editing
Wang, S., Zhang, Z., Tang, R., He, F., Huang, Y., Nie, Z., & Lei, C. (2022) · Science China Chemistry · doi:10.1007/s11426-022-1376-1 · Cited by 15
Recent Progress of Rational Modified Nanocarriers for Cytosolic Protein Delivery
He, X. D., Su, X., Sun, Y., Zhong, M., Xiao, N., Zhou, Z., Wang, T., Tang, Y., & Xie, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061610 · Cited by 14
In vivo delivery systems for CRISPR genome editing: Viral and non-viral carriers
Lee, Y., Kim, B., Lee, D., Cheon, S. Y., Lim, S. G., Kim, Y., & Koo, H. (2025) · Applied Physics Reviews · doi:10.1063/5.0228874 · Cited by 13
Preparation of Cas9 Ribonucleoproteins for Genome Editing
Lin, S., Nguyen, V. Q., & Lin, S. (2022) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4420 · Cited by 13
CRISPR-Cas9 as a Potential Cancer Therapy Agent: An Update
Sadr, S., Simab, P. A., & Borji, H. (2023) · Research in Biotechnology and Environmental Science · doi:10.58803/rbes.2023.2.1.02 · Cited by 12
Increasing the precision of gene editing in vitro, ex vivo, and in vivo
Mueller, K. P., Carlson-Stevermer, J., & Saha, K. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.08.006 · Cited by 12
A ligand-based system for receptor-specific delivery of proteins
Maffei, M., Morelli, C., Graham, E., Patriarca, S., Donzelli, L., Doleschall, B., Reis, F. D. C., Nocchi, L., Chadick, C. H., Reymond, L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-55797-1 · Cited by 13
Bioorthogonal CRISPR/Cas9‐Drug Conjugate: A Combinatorial Nanomedicine Platform
Beha, M. J., Kim, J., Im, S. H., Kim, Y., Yang, S., Lee, J. H., Nam, Y. R., Lee, H., Park, H., & Chung, H. J. (2023) · Advanced Science · doi:10.1002/advs.202302253 · Cited by 11
Jakka, S. R., Govindaraj, V., & Mugesh, G. (2019) · Angewandte Chemie · doi:10.1002/ange.201902347 · Cited by 11
Jakka, S. R., & Mugesh, G. (2025) · Chemistry - An Asian Journal · doi:10.1002/asia.202401734 · Cited by 10
Carter, S. R., & Warner, C. M. (2018) · Health Security · doi:10.1089/hs.2018.0067 · Cited by 10
Applying switchable Cas9 variants to in vivo gene editing for therapeutic applications
Mills, E. M., Barlow, V. L., Luk, L. Y. P., & Tsai, Y. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09488-2 · Cited by 10
A Coordinative Dendrimer Achieves Excellent Efficiency in Cytosolic Protein and Peptide Delivery
Ren, L., Lv, J., Wang, H., & Cheng, Y. (2019) · Angewandte Chemie · doi:10.1002/ange.201914970 · Cited by 10
Cytogel: A Cell-Crosslinked Thermogel
Piao, Z., Park, J. K., & Jeong, B. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c01457 · Cited by 10
Zheng, Q., Wang, W., Zhou, Y., Mo, J., Chang, X., Zha, Z., & Zha, L. (2023) · Biomaterials Science · doi:10.1039/d3bm00788j · Cited by 12
Rational design of diblock copolymer enables efficient cytosolic protein delivery
Zhao, H., Zhang, C., Tian, C., Li, L., Wu, B., Stuart, M. A. C., Wang, M., Zhou, X., & Wang, J. (2024) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2024.06.123 · Cited by 9
Cas9 conjugate complex delivering donor DNA for efficient gene editing by homology-directed repair
Kang, Y. K., Lee, J. H., Im, S. H., Lee, J. H., Jeong, J., Kim, D. K., Yang, S. Y., Jung, K., Kim, S., & Chung, H. J. (2021) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2021.07.009 · Cited by 9
Dynamic sampling of a surveillance state enables DNA proofreading by Cas9
Paula, V. S. D., Dubey, A., Arthanari, H., & Sgourakis, N. G. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.10.001 · Cited by 8
Sellers, D. L., Lee, K., Murthy, N., & Pun, S. H. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.057 · Cited by 8
Glyco-nanomaterials as a therapeutic target in drug delivery and biomedicine: A review
Dessai, A. D., Nair, A., Selvasudha, N., Garg, S., & Nayak, U. Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147830 · Cited by 8
Shalaby, K. E., Aouida, M., Gupta, V. R., Ghanem, S. S., & El‐Agnaf, O. M. A. (2022) · Frontiers in Genome Editing · doi:10.3389/fgeed.2022.854866 · Cited by 7
GalNAc- or Mannose-PEG-Functionalized Polyplexes Enable Effective Lectin-Mediated DNA Delivery
Steffens, R. C., Folda, P., Fendler, N. L., Höhn, M., Bücher, K. S., Kempter, S., Snyder, N. L., Hartmann, L., Wagner, E., & Berger, S. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00546 · Cited by 8
Tissue-Specific Delivery of Oligonucleotides
Xia, X., Pollock, N., Zhou, J., & Rossi, J. J. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9670-4_2 · Cited by 8
Noel, E. A., Sahu, S. U., Wyman, S. K., Krishnappa, N., Jeans, C., & Wilson, R. C. (2025) · The CRISPR Journal · doi:10.1089/crispr.2024.0080 · Cited by 6
Self-citationZhang, C., Zhang, N., Yang, R., Qi, X., Huang, J., Liu, J., Li, S., Lovell, J. F., Ren, H., & Zhang, Y. (2025) · BMEMat · doi:10.1002/bmm2.70032 · Cited by 6
Minimization of the E. coli ribosome, aided and optimized by community science
Tangpradabkul, T., Palo, M. Z., Townley, J., Hsu, K. B., Participants, E., Smaga, S., Das, R., & Schepartz, A. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad1254 · Cited by 6
Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells
Wang, Q., Aliyu, L., Chung, C., Rosenberg, J. N., Geng, Y., & Betenbaugh, M. J. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3878-1_16 · Cited by 5
Song, N., Tao, R., Li, H., Zhang, R., Huang, Y. H., Zhang, L., Liu, Y., Yang, D., & Yao, C. (2025) · Angewandte Chemie · doi:10.1002/ange.202500566 · Cited by 11
Antibody-mediated delivery of CRISPR-Cas9 ribonucleoproteins in human cells
Ubiparipovic, S., Christ, D., & Rouet, R. (2022) · Protein Engineering Design and Selection · doi:10.1093/protein/gzac011 · Cited by 5
Self-citationThe Synergy between CRISPR and Chemical Engineering
Lau, C., & Tin, C. (2019) · Current Gene Therapy · doi:10.2174/1566523219666190701100556 · Cited by 5
Facile synthesis of GalNAc monomers and block polycations for hepatocyte gene delivery
Bockman, M. R., Dalal, R. J., Kumar, R., & Reineke, T. M. (2021) · Polymer Chemistry · doi:10.1039/d1py00250c · Cited by 4
Shao, Q., Shen, C. ‐. J., You, W., Nie, X., Huang, W., Gao, F., Zhou, X., Wang, L., Wang, L.-H., Chen, G., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155596 · Cited by 4
Han, Z. Z., & Schultz, M. C. (2022) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.202100283 · Cited by 4
Protein Modifications for Cellular Protein Delivery
Arafiles, J. V. V., Franke, J., Dubatouka, P., Franz, L., & Hackenberger, C. P. R. (2026) · Chemical Reviews · doi:10.1021/acs.chemrev.6c00267 · Cited by 3
Biomimetic Approaches for Biomaterials Development
Choudhury, S., Arjun, K. R., Bharadwaj, M. N. R., Maghimaa, M., & Basalingappa, K. M. (2023) · Engineering materials · doi:10.1007/978-981-99-6698-1_5 · Cited by 3
Pasch, T., Bäumer, N., Bäumer, S., Buchholz, F., & Mootz, H. D. (2024) · Journal of Peptide Science · doi:10.1002/psc.3592 · Cited by 3
“11 Antibodies are the prime reagents for cell-specific targeting in a more general manner through various cell-specific epitopes.”
BackgroundEfficient Direct Cytosolic Protein Delivery via Protein-Linker Co-engineering
Wei, L., Wang, H., Özkan, M., Damian‐Buda, A., Loynachan, C. N., Liao, S., & Stellacci, F. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c02360 · Cited by 2
Li, L., Jing Hua, H. U., Yang, W. J., & Li, J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114495 · Cited by 2
Calcium Shock Enables Efficient and Programmable Particle Delivery for Genome Editing Applications
Vo, N., de Oñate, L., Frank, M., Hu, X., Blackburn, S. M., Foss, D. V., Villegas, J., Asija, K., Hockemeyer, D. F., Fu, H., et al. (2026) · Advanced Science · doi:10.1002/advs.202510441 · Cited by 2
“Current intracellular delivery protocols, in addition to inefficiency, also lack cell type specificity, making it difficult to target delivery to specific cell types or states, which limits both research and clinical applications [ 9, 13 ].”
InfluentialSelf-citationMulticellular systems to translate somatic cell genome editors to human
Hernandez‐Gordillo, V., Casolaro, T. C., Ebrahimkhani, M. R., & Kiani, S. (2020) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2020.100249 · Cited by 2
Fire Burn and Cauldron Bubble: What Is in Your Genome Editing Brew?
Patange, S., & Maragh, S. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00431 · Cited by 2
Foss, D. V., & Norris, A. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-817218-6.00011-5 · Cited by 2
Therapeutic application of sequence-specific binding molecules for novel genome editing tools
Nakao, J., Yamamoto, T., & Yamayoshi, A. (2021) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2021.100427 · Cited by 2
A slow-exchange conformational switch regulates off-target cleavage by high-fidelity Cas9Preprint
Paula, V. S. D., Dubey, A., Arthanari, H., & Sgourakis, N. G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.06.413757 · Cited by 2
Efficient in vivo mammalian neuron editing using peptide-mediated CRISPR enzyme deliveryPreprint
Manohar, B. D., Travis, M., Munjal, V., Baehr, C. M., Rahnama, L. M. A., Kang, M. H., Haddad, R. F., Asija, K., Noel, E. A., Peddireddy, N., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.26.690638 · Cited by 3
Self-citationFunctional peptide-assisted delivery of CRISPR/Cas9: recent progress on gene editing
Cho, H. M., Ryu, Y. C., Cho, M. K., & Hwang, B. H. (2026) · Biomaterials Science · doi:10.1039/d6bm00231e · Cited by 1
Taharabaru, T., Motoyama, K., Wen, Y., Zhang, Z., Tian, X., Li, J., & Higashi, T. (2026) · Advanced Science · doi:10.1002/advs.75996 · Cited by 1
Nanoengineering Systems for Gene Therapy: Mechanisms, Modalities, and Future Directions
Mais, R., Kumar, A., Ahmetaj, A. A., Burgos-Crespo, G., Sanchez, M. M., Roxas, D., Dcosta, C., Ilyas, A., Hadjiargyrou, M., & Zanganeh, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27135988 · Cited by 1
“Most of these added-complexity systems remain preclinical because each component increases characterization, scale-up, and regulatory requirements [157,163].”
Receptor Mediated Delivery of Cas9-Nanobody Induces Cisplatin Synthetic Dose SensitivityPreprint
Roche, P. J. R., Gytz, H., Hussain, F., Liang, Y., Laursen, N. S., Andersen, K. R., Nagar, B., & Akavia, U. D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/389122 · Cited by 1
Biomaterials for gene editing therapeutics
Shim, G., Kim, D., Le, Q., Byun, J., Park, J.-W., & Oh, Y. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102983-1.00008-9
Engineering and Delivery of Synthetic Chromatin Effectors
Tekel, S. J. (2019)
Novel Cell-Penetrating Peptides in the Delivery of Functional Protein Conjugates Into Living Cells
Schneider, A. F. L. (2021) · Refubium (Universitätsbibliothek der Freien Universität Berlin) · doi:10.17169/refubium-29487 · Cited by 1
Suh, Y. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738498138.793579901
Genome Editing with CRISPR‐Cas Systems
Lotfy, P., & Hsu, P. D. (2022) · Wiley eBooks · doi:10.1002/9781683673798.ch11 · Cited by 1
Chen, J. (2025) · eScholarship@McGill (McGill) · doi:10.82308/51400
An AIEgen-Based Carrier Enables Efficient Cytosolic Delivery of Bioactive Proteins
Yang, Y. C., Jia, H., Yang, L., He, B., Zhang, K., & Liu, H. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s557672
Nouvelle génération d’AAV : un mélange de chimie organique et de vectorologie
Lalys, P.-A. (2023) · theses.fr (ABES) · doi:10.70675/b6df86c2z6520z473ez9e10ze1740b9bc3ae
Molecular Engineering of CRISPR Nanomaterials toward Cancer Theranostics
Li, G., Wang, S., & Zhang, J. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.6c00121
Halogen Bonding as a Molecular Recognition Strategy for Genetic Code Expansion.
Jakka, S. R., Jaiswal, S., Reddy, K. M., Agarwal, R., Kumar, S., & Mugesh, G. (2026) · Angewandte Chemie · doi:10.1002/anie.5508153
Halogen Bonding as a Molecular Recognition Strategy for Genetic Code Expansion
Jakka, S. R., Jaiswal, S., Reddy, K. M., Agarwal, R., Kumar, S., & Mugesh, G. (2026) · Angewandte Chemie · doi:10.1002/ange.5508153
Stenzel, A. F., Athanasiadis, A., Dangas, G., Park, P., Maslarinou, A., Moschogianni, E., Cataneo, A. H. D., Freije, C. A., Zhou, Y., Levenson, K. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.10.743996
Abbasi, S., Bockley, K. M., Dohr, J., Chen, E., Carter, D. M., Berlinicke, C. A., Lian, X., Viskadourou, M., Burke, E. V., Ensign, L. M., et al. (2026) · ACS Nano · doi:10.1021/acsnano.6c10855
Graham, J. P., Wheeler, E. E., Leach, K. J., & Gonzalez‐Fernandez, T. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.18.751510
Mohiuddin, M., & Ahsan, M. A. M. (2026) · Health Science Reports · doi:10.1002/hsr2.73308
“Significant success has been achieved in engineering Cas9 proteins to enhance their specificity [78, 79].”
Das, P., Samoi, T. B., & Maji, B. (2026) · Chemical Communications · doi:10.1039/d6cc01929c
Nano Delivery Systems for In Vivo CRISPR/Cas-Based Gene Therapy: From Vectors to Clinical Outcomes
Chen, R., Zhou, H., Wu, Q., & Gong, C. (2026) · ACS Nano · doi:10.1021/acsnano.6c12154
Metadata
- Authors
- Rouet, R., Thuma, B. A., Roy, M. D., Lintner, N. G., Rubitski, D. M., Finley, J. E., Wisniewska, H. M., Mendonsa, R., Hirsh, A., de Oñate, L., Compte Barrón, J., McLellan, T. J., Bellenger, J., Feng, X., Varghese, A., Chrunyk, B. A., Borzilleri, K., Hesp, K. D., Zhou, K., Ma, N., Tu, M., Dullea, R., McClure, K. F., Wilson, R. C., Liras, S., Mascitti, V., & Doudna, J. A.
- Affiliations
- QB3 (US)
- Pfizer (United States) (US)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Liras, Spiros
- Mascitti, Vincent
- Doudna, Jennifer A.
- ORCID
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-04-18
- Volume
- 140
- Issue
- 21
- Pages
- 6596-6603
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- PMC
- PMC6002863
- OpenAlex
- W2801459452
- Cited by
- 163
- References
- 48
- Citations by year
- 2026: 14 · 2025: 13 · 2024: 15 · 2023: 16 · 2022: 22 · 2021: 21 · 2020: 24 · 2019: 26 · 2018: 12
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Chemical Society (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Health and Medical Research Council (APP1090875)
- Pfizer (86059)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR/Cas9, asialoglycoprotein receptor, receptor-mediated delivery, ribonucleoprotein, endocytosis, hepatocytes, genome editing
- MeSH terms
- Gene Editing, Endonucleases, Humans, Protein Engineering, Molecular Structure, Cell Line, Tumor, Hep G2 Cells, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.